$$ D E T O N A T I O N $$
http://www.genesis-technology.net
oder ein Bericht auf MoneyTV
http://www.moneytv.net/
Aus dem WO Forum habe ich diesen Link
http://www.stockta.com/cgi-bin/analysis.pl?symb=GTEC&num1=17…
Wo Genesis auf Grund von Candlestick Analyse als "very bullish" bewertet wird. Bin sehr zuversichtlich, dass Genesis seinen Weg geht, jetzt wo wohl zum ersten Mal schwarze Zahlen geschrieben werden. + Beteiligungen and Sunwin und Lotus.
Gibt sogar einen Munich Director, Manuel Richter, wie man den Fotos entnehmen kann. Alles wird gut.
News , chart, profile, more
Last: 0.18-0.01-5.41%
12:21am 05/23/2006
Delayed quote dataAdd to portfolio
Analyst
Create alertInsider
Discuss
Financials
Sponsored by:
GTEC0.18, -0.01, -5.4%) , a Chinese marketing and investment services company, conducted its Annual Shareholders Meeting on Friday, May 19th, at Beijing's China World Hotel. For those shareholders unable to attend, a synopsis follows:
-- The Company is cash flow positive and only growing stronger; its
clients are increasing in numbers and quality. Management remains
confident that the Company continues on the right course, as
profitability and sustainability remain the primary goal. The next
quarterly report should support this commitment.
-- The opportunity for merger has been a key focus since December
2005. Auditing issues, not to mention the expense of an audit has
been a concern for both parties. However, several other merger
opportunities have presented themselves to Genesis, including
another Chinese company that had over $300 million in revenues last
year. Possible merger candidates with Genesis should be nothing
short of enormous, from financial strength, market sector, to
management. Director Shaohua Tan concluded: "We are in an
excellent position. Our Chinese network and our growing financial
strength have provided us with this luxury. Completing a merger
that will enhance our shareholders' position is a top priority.
For good measure, management must revise its previous timeline
forecast."
-- The progress of Gold Horse International and Lotus Pharmaceuticals,
Genesis' equity partners, is excellent. In less than 90 days, both
companies could be trading, thus dramatically increasing the net
asset value of Genesis. Genesis provides a full circle, turn-key
service for partner companies. Genesis could have an admirable
equity position in five to 10 new public companies within the next
nine months in addition to its six current investments. When
partner companies begin to increase in market cap, as anticipated,
the net asset value of Genesis will increase as well. Prospective
investors can invest in Genesis, thus investing in as many as 10
different companies. If investors determine to invest only in
Lotus Pharmaceuticals, for example, Genesis would still receive
direct benefit.
-- From February 1st to the third week of May, the Company increased
in value about 500%. Seldom do public -- especially NASDAQ Bulletin
Board -- companies show straight line growth, as GTEC rose as much
as 1000% during the interim period. Management is unconcerned
about the vagaries of the day-trading market, as it is only
increasingly confident about the Company's successful business
model and future achievements. Management adheres to "let the
market be your guide" and that the long view is the only
significant perspective.
Chairman Gary Wolfson summarized the two hour, bilingual summit: "In our first four years as a listed company, 2006 is, by far, our best year to date. We are confident that our model will only improve, providing an excellent return to shareholders. We could not be more encouraged. We discussed the three major interest points: the Company's performance since February 1st, the status of the avidly discussed merger opportunity, and -- perhaps most important -- what we believe the future holds."
Kenneth Clinton, Genesis President, said: "Our New York auditor completed a 3-week visit to China, and our CFO joined us here now. These companies should be listed companies in the U.S. -- to the benefit of Genesis, Gold Horse and Lotus shareholders -- in 2006. Of course, we expect to announce several new Chinese clients promptly that could, in turn, be trading by year end."
A full power point of the proceedings is available on the company's website at www.genesis-technology.net
Bin durch den "Aktionär" in GTC rein geschlittert und weiß so gut wie nix, ausser das ich 50% im Minus bin.
Ich weiß war ziemlich blauäugig... Vielleicht steigt ja der Kurs und ich kann irgendwann plus-minus null raus.....
Net income (loss) per common share ............... $ 0.00 $ (0.02) At March 31, 2006, we had a cash balance of $889,204 and working capital of $1,615,030
Chairman Gary Wolfson summarized the two hour, bilingual summit: "In our first four years as a listed company, 2006 is, by far, our best year to date."
Die machen in China sowas wie GCI Management in Deutschland,sie beteiligen sich an chinesischen Firmen und bringen sie an die Börse in USA
Die Firma ist cash flow positive und wächst,ihre Kunden nehmen zu an Zahl und Qualität
GTEC hält grösseren Anteil an Lotus Pharmaceuticals,die in Bälde in USA durch Reverse Merger gelistet werden sollen.Deren Umsatz hat sich seit März 2006 um 30% verbessert und GTEC meint, es könne in diesem Jahr insgesamt 2 Millionen verdienen.
Sie haben einen LOI mit The YaSheng Group, Ltd.zum Zusammenschluss.Yasheng ist ein Biotech/Agribusiness Conglomerat in Gansu Province und gehört dem Staat,die offizielle Erlaubnis liegt vor.Yasheng wäre dann Mehrheitsaktionär.Der Merger muss noch durch die Aktionäre von GTEC akzeptiert werden
Ich halte noch ein wenig von den Dingern. Denke wir sehen die 0,40 dieses Jahr wieder.
BOCA RATON, Fla., Jul 3, 2006 (PRIMEZONE via COMTEX) -- Genesis Technology Group, Inc. (GTEC : genesis technology group inc com
News , chart, profile, more
Last: 0.19+0.01+2.70%
3:40pm 07/03/2006
Delayed quote dataAdd to portfolio
Analyst
Create alertInsider
Discuss
Financials
Sponsored by:
Get up to 50 free trades at TD AMERITRADE.GTEC0.19, +0.01, +2.7%) announced that it has terminated negotiations with the western Chinese conglomerate to complete a merger with one of its subsidiaries. Genesis management stated that it has upgraded the required qualifications for merger candidates, as the Company finds itself in a significantly improved position from last December, when such negotiations commenced.
Gary L. Wolfson, Genesis Chief Executive Officer, commented: "Frankly, we did not anticipate our Company's improvement to occur so rapidly in 2006. The merger proposal formulated in mid-December was not nearly as attractive this spring. Genesis terminated negotiations only after performing arduous due diligence to reach this conclusion.
"Management is dedicated to increasing shareholder value, and we remain convinced that a merger with a qualified Chinese company should accelerate that goal. With our well-defined Chinese partners program, we can now consider new Genesis merger candidates on a regular basis. Additionally, with three quarters of solid performance, significant cash reserves, and appreciating equity holdings, Genesis will be in an enviable position to complete such a merger in the future."
Dr. Shaohua Tan, Director of China Operations, added: "Our revitalized business model is moving forward at full throttle. Of our contract partner companies, Lotus Pharmaceuticals, will be the first to be publicly traded. The audit is in its final stages. Gold Horse International will follow soon thereafter. New partner companies will be announced shortly, and we remain confident that each completed contract could result in about $2 million to the Genesis bottom line."
CHANGE OF ADDRESS NOTICE: Effective July 1, 2006, the main office for all China operations shall be Oriental Plaza, Level 6, Tower W2, One East Chang An Avenue, Dong Cheng District, Beijing 100738, People's Republic of China.
Optionen
| Boardmail an "Jorgos" |
Wertpapier: EUTEX EUROPEAN TELCO |
Außerdem sind seit gut ner Woche endlich wieder steigende Umsätze da!!!!
http://www.marketwatch.com/tools/quotes/quotes.asp?symb=gtec&siteid=
gruß
Optionen
| Boardmail an "Jorgos" |
Wertpapier: EUTEX EUROPEAN TELCO |